Current Problems in Cardiology
Volume 34, Issue 4 , Pages 145-217, April 2009

Coronary Computed Tomography and Magnetic Resonance Imaging

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The use of gadolinium chelates for cardiovascular magnetic resonance imaging as discussed in this article is off-label and not FDA-approved.

 Eike Nagel is a consultant to Berlex/Schering and Bracco.

 Jörg Barkhausen receives honorariums from Schering and Siemens, receives research grants from Schering and Guerbet, is a consultant for Schering and Guerbet, and is on the advisory board of Guerbet.

 Paul Schoenhagen receives an honorarium from Takeda Pharmaceuticals (paid directly to charity and higher education).

 Thomas C. Gerber is an associate editor of Mayo Clinic Proceedings.

 The authors have no other conflicts of interest to disclose.

 This work was supported in part by NIH Grant 1R01EB007986-02 (“Noninvasive Localization of Vulnerable Plaques”) awarded to Dr. Birgit Kantor.

PII: S0146-2806(08)00184-9

doi:10.1016/j.cpcardiol.2008.12.002

Current Problems in Cardiology
Volume 34, Issue 4 , Pages 145-217, April 2009

Article Tools

* Image Usage & Resolution